about
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsAntigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" miceA senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.Targeting unique metabolic properties of breast tumor initiating cellsDelta-like1-induced Notch1 signaling regulates the human plasmacytoid dendritic cell versus T-cell lineage decision through control of GATA-3 and Spi-B.miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerTargeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophagesIL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesisSTAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice.Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation.Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland.Cell-intrinsic TLR2/MyD88 pathway in breast and colon cancer.STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression.A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.AID splice variants lack deaminase activity.Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis.Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation.SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killingMetabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling.Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapySingle-cell transcriptional diversity is a hallmark of developmental potentialFunctional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringA mouse model that is immunologically tolerant to reporter and modifier proteins
P50
Q24631515-DBBD8A41-C2EC-4398-91A4-F8F1E5CB37D9Q28740998-58F43B70-E42E-46B5-9241-82F85E1F7A61Q28749033-22CB03BA-4259-4ACC-86CA-0B289D3A552BQ30828170-6B696410-8A95-4F8A-864D-077CF8DBC60BQ34089425-C4794E5A-7C52-45D2-B197-EE024EAD1B7AQ34471383-455340C4-6EF4-4A60-9CAC-9A38BC513BBFQ34529305-1E0399EE-5D78-4512-AC34-9D1D2AAFD69EQ35485418-2B84E0BF-A435-430F-80C2-92E0D7715061Q35833184-145540F0-F449-4F32-985D-13A498EEB8DAQ35993592-BFE8B50E-C243-4DB8-BD8D-46BDC8E0E10EQ36591359-9DBD5ADF-6D7F-404D-8C5C-6909B5BDB670Q36677337-178B4E43-F7D7-4A3B-8489-B85669394494Q36843718-D8B6D6BC-0848-44AF-9857-CEACB940313DQ37548319-5043D1DC-571D-48AA-A578-C46E60A48280Q37568043-45BDCF3D-53E0-4FA3-A85A-45E2940DA210Q39761197-7FCA427D-3A56-451F-A85B-A074ADA6AF8DQ42503735-E7708349-502F-451B-8A24-A2758745387FQ43211553-EE22C4C8-F26F-4A36-9F81-306292878775Q45265413-841DF0F9-F23E-4CAE-8CF5-F993D8DC2C4BQ45976947-04A44C1E-961A-4258-B187-2E14853F203FQ46116559-7B7D2501-0D62-4B58-ADEA-42AA08D076E9Q47104789-17EBA378-BE59-4E05-B98E-8C90B795E87FQ50607885-747E1098-19E8-478B-80E6-25CB3AC6C6B8Q51916152-1A7B1DE8-0972-4E53-9243-2E51E5A750ABQ64238411-BFDEA9A7-EEBC-4CCC-9F14-FC891BD962C8Q64950563-EA024EF4-248F-41AA-A81C-83E3C417A14CQ92129139-2297172D-0D8B-4963-BA00-8B0CCEF2B7DFQ92889193-C2346C5E-E51D-4C04-8537-6001EE42B716Q93137319-B3D154D6-AD80-4380-AF4C-454F91387226Q96022729-29F32F43-0A21-45E6-80F7-BDF9B95DFF46
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ferenc A Scheeren
@ast
Ferenc A Scheeren
@en
Ferenc A Scheeren
@es
Ferenc A Scheeren
@nl
Ferenc A Scheeren
@sl
type
label
Ferenc A Scheeren
@ast
Ferenc A Scheeren
@en
Ferenc A Scheeren
@es
Ferenc A Scheeren
@nl
Ferenc A Scheeren
@sl
prefLabel
Ferenc A Scheeren
@ast
Ferenc A Scheeren
@en
Ferenc A Scheeren
@es
Ferenc A Scheeren
@nl
Ferenc A Scheeren
@sl
P106
P21
P31
P496
0000-0002-8304-9023